Home » Topics » Regulatory » Patents

Patents
RSS

New JAK inhibitors synthesized at Guangzhou Innocare Pharma Tech

Jan. 19, 2021

Guangdong Newopp Biopharmaceuticals identifies mutant KRAS inhibitors

Jan. 19, 2021

Hangzhou Hertz Pharmaceutical patents casein kinase 1 isoform epsilon inhibitors

Jan. 19, 2021

New CDK9/cyclin T1 inhibitors discovered at Medshine Discovery

Jan. 19, 2021

Shanghai Institute of Materia Medica dicloses new hepatitis B virus inhibitors

Jan. 19, 2021

Nanjing Sanhome Pharmaceutical patents PRMT5 inhibitors

Jan. 18, 2021

BioWorld MedTech Patent Highlights: Week 1

From Current Patent Gazette

Jan. 15, 2021

BioWorld MedTech presents Patent Highlights, an excerpt of the most important med-tech patents from this week's Cortellis Patents Gazette.

Investigators present new antibodies for malaria

Jan. 15, 2021

Array BioPharma discloses BRAF mutant inhibitors

Jan. 15, 2021

CanSino Biologics patents glycoconjugates as vaccines for pneumococcal infections

Jan. 15, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...